Skip to main content
. 2018 Aug 31;9(68):33043–33049. doi: 10.18632/oncotarget.25984

Figure 3.

Figure 3

The evolution of creatinine (A), aspartate aminotransferase (AST) and alanine aminotransferase (ALT) (B), and bilirubin (C) levels during nivolumab treatment. Green arrow represents nivolumab treatment. Green stars represent irAE events. Red stars represent liver flare progression. Time is expressed on weeks from start of nivolumab treatment.